BIOAGE LABS INC (BIOA) Stock Cash Flow
USA - NASDAQ:BIOA - US09077V1008 - Common Stock
7.545 USD
-0.41 (-5.09%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -79.03M | -71.11M | -63.85M | -39.72M | |||
| Depreciation Amortization | 180.00K | 167.00K | 162.00K | 129.00K | |||
| Change In Working Capital | 10.49M | 11.18M | 6.71M | 795.00K | |||
| Interest Paid | 1.00M | 1.42M | 1.16M | 129.00K | |||
| Other non cash items | 10.95M | 8.24M | 19.62M | 2.62M | |||
| OPERATING CASH FLOW | -57.40M | -51.52M | -37.36M | -36.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -916.00K | -366.00K | -166.00K | -103.00K | |||
| Other Investing Activity | N/A | N/A | -100.00K | 0.00 | |||
| INVESTING CASH FLOW | -93.96M | -366.00K | -266.00K | -103.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | -6.00M | -6.00M | 11.50M | 2.50M | |||
| Stock Issued/Repurchased | 222.37M | 392.25M | 23.50M | 44.00K | |||
| Other Financing Activity | -3.79M | -5.05M | -63.00K | -45.00K | |||
| FINANCING CASH FLOW | 212.59M | 381.20M | 34.94M | 2.50M | |||
| Exchange Rate Effect | 21.00K | 81.00K | 0.00 | 246.00K | |||
| CHANGE IN CASH | 61.24M | 329.39M | -2.69M | -33.54M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -57.40M | -51.52M | -37.36M | -36.18M | |||
| Capital Expenditure | -916.00K | -366.00K | -166.00K | -103.00K | |||
| FREE CASH FLOW | -58.32M | -51.89M | -37.53M | -36.28M | |||
All data in USD